LONDONER KENNETH L

About LONDONER KENNETH L

Kenneth L. Londoner is best known as the founder, Chairman, and Chief Executive Officer of BioSig Technologies, Inc., a U.S.-listed medical technology company focused on cardiac signal visualization and arrhythmia analysis. His career has been closely tied to medtech innovation, company building, and the commercialization of technologies intended to improve the quality and interpretability of intracardiac signals. At BioSig, he helped shape the company’s strategic direction around the PURE EP™ platform, which is designed to provide greater clarity in arrhythmia identification and cardiac electrophysiology workflows. Across his broader career, Londoner has been active in leadership, investing, and business development roles in healthcare and medical devices. Corporate filings show that he also served as a director of MedClean Technologies, Inc., and that he was involved as a business partner and investor in InspireMD, another medical device company. These roles suggest a consistent focus on healthcare innovation, early-stage company development, and strategic growth opportunities in regulated industries. At BioSig, Londoner’s most visible contribution has been as a founder-led executive with responsibility for long-term vision, corporate positioning, and strategic execution. The company’s core mission has been to reduce noise and interference in cardiac recordings, helping physicians interpret signals more clearly during procedures such as cardiac ablations. BioSig has also highlighted initiatives involving artificial intelligence and software-enabled healthcare applications, indicating an effort to extend the company’s platform beyond hardware into broader digital health capabilities. Overall, Kenneth L. Londoner can be characterized as an entrepreneurial medtech executive with experience in company formation, governance, capital markets positioning, and product strategy. For SEO purposes, he is appropriately described as a founder and public-company leader in cardiovascular technology, with a career centered on medical device innovation, strategic growth, and clinical problem-solving.